These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 141327)

  • 1. Calusterone therapy for advanced breast cancer.
    Aslam J; Maxwell I
    Cancer Treat Rep; 1977; 61(3):371-3. PubMed ID: 141327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical considerations on the use of a new synthetic androgen, Calusterone, in the treatment of advanced breast cancer].
    de Matteis A; Perrone V; Marone A
    Minerva Med; 1977 Jul; 68(36):2499-504. PubMed ID: 142218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calusterone (7-beta, 17-alpha-dimethyltestosterone) in the palliative treatment of advanced breast cancer].
    Robustelli Della Cuna G; Bernardo G; Strada MR
    Minerva Med; 1977 Oct; 68(52):3555-63. PubMed ID: 74052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
    Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC
    Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases].
    Brule G; Chauvergne J; Clavel B; Gary-Bobo J; Gurrin J; Klein T; Pommatau E
    Sem Hop; 1974 Dec 8-14; 50(50-51):3099-105. PubMed ID: 4377318
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study.
    Samal B; Jones S; Brownlee RW; Morrison F; Hoogstraten B; Caoili E; Baker L
    Cancer Treat Rep; 1978 Jan; 62(1):19-22. PubMed ID: 342093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male breast cancer: two cases with objective regressions from calusterone (7 alpha, 17 beta-dimethyltestosterone) after failure of orchiectomy.
    Horn Y; Roof B
    Oncology; 1976; 33(4):188-91. PubMed ID: 190574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Calusterone (NSC-88536) in advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1976 Mar; 60(3):220-1. PubMed ID: 130973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitumoral activity of calusterone in advanced mammary carcinoma (author's transl)].
    Rosso R; Brema F; Porcile GF; Santi L
    Tumori; 1976; 62(1):79-84. PubMed ID: 138231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calusterone.
    Brodkin RA; Cooper MR
    Ann Intern Med; 1978 Dec; 89(6):945-8. PubMed ID: 152592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 7beta, 17alpha-dimethyltestosterone (calusterone) on cortisol metabolism in women with advanced breast cancer.
    Fukushima DK; Zumoff B; Bulkin W; Hellman L
    J Clin Endocrinol Metab; 1976 Jul; 43(1):38-45. PubMed ID: 133118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficacy of 7 beta, 17 alpha-dimethyltestosterone (Calusterone) in advanced female breast cancer.
    Gordan GS; Halden A; Walter RM
    Calif Med; 1970 Sep; 113(3):1-10. PubMed ID: 5457511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calusterone for breast cancer.
    Med Lett Drugs Ther; 1973 Nov; 15(23):95. PubMed ID: 4746413
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S; Krasnokuki D; Hochman A; Brufman G
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
    Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
    Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with furanidyl-fluorouracil in advanced tumours of the breast.
    Cichy A; Jurga L; Klvana M
    Neoplasma; 1974; 21(6):723-32. PubMed ID: 4614094
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
    Martoni A; Pacciarini MA; Pannuti F
    Drugs Exp Clin Res; 1985; 11(2):127-31. PubMed ID: 3915281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.